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A systematic review and meta-analysis of 
the diagnostic accuracy of the Phototest 
for cognitive impairment and dementia
Cristóbal Carnero-Pardo1,2, Samuel Lopez-Alcalde1,2, Ricardo Francisco Allegri3, María Julieta Russo3
Abstract. The recently developed Phototest is a simple, easy and very brief test for detecting cognitive impairment or 
dementia. Objective: To evaluate the diagnostic accuracy of the Phototest for detecting cognitive impairment or dementia. 
Methods: We used a manually created database to search for studies evaluating the Phototest diagnostic yield and 
performed an initial meta-analysis to determine sensitivity (Sn) and specificity (Sp) of diagnostic parameters. We also 
performed a second meta-analysis of individual participant data. Results: In total, 6 studies were included in the meta-
analysis. For dementia, Sn was 0.85 (95% CI, 0.82-0.88) and Sp 0.87 (95% CI, 0.85-0.99); for cognitive impairment, Sn 
was 0.80 (95% CI, 0.77-0.92) and Sp 0.88 (95% CI, 0.86-0.90). In the individual data meta-analysis, 1565 subjects were 
included, where best cut-off points for dementia and for cognitive impairment were 26/27 (Sn=0.89 (95% CI 0.85-0.91), 
Sp=0.84 (95% CI, 0.82-0.91)) and 28/29 (Sn=0.79 (95% CI, 0.76-0.81), Sp=0.88 (95% CI, 0.86-0.90)), respectively. 
Conclusion: Phototest has good diagnostic accuracy for dementia and cognitive impairment. It is brief, simple and can be 
used in illiterate persons. This makes it suitable for use in primary care settings and/or in subjects with low educational level. 
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REVISÃO SISTEMÁTICA E META-ANÁLISE DA ACURÁCIA DIAGNÓSTICA DO PHOTOTEST EM COMPROMETIMENTO COGNITIVO 
E DEMÊNCIA
RESUMO. Phototest é um teste simples, fácil e muito rápido para detecção de comprometimento cognitivo e demência 
recentemente desenvolvido. Objetivo: Avaliar a acurácia diagnostica do Phototest para detecção de comprometimento 
cognitivo e demência. Métodos: Nós usamos um banco de dados manualmente criado para estudos que avaliassem a 
capacidade diagnóstica do Phototest e realizamos uma meta-análise para determinar a sensibilidade (Sn) e especificidade 
(Ep) dos parâmetros diagnósticos. Nós também realizamos uma segunda meta-análise dos dados individuais dos 
participantes. Resultados: Um total de seis estudos foram incluídos na meta-análise. Para demência a Sn foi 0.85 (95% 
CI, 0,82-0,88) e Ep 0,87 (95% CI, 0,85-0,99); para comprometimento cognitivo a Sn foi 0,80 (95% CI, 0,77-0,92) e Sp 
0,88 (95% CI, 0,86-0,90). Na meta-análise de dados individuais, 1565 foram incluídos, os melhores escores de corte 
para demência e para comprometimento cognitivo foram 26/27 (Sn=0,89 (95% CI 0,85-0,91), Ep=0,84 (95% CI, 0,82-
0,91)) e 28/29 (Sn=0,79 (95% CI, 0,76-0,81), Ep=0,88 (95% CI, 0,86-0,90)), respectivamente. Conclusão: Photest tem 
boa acurácia diagnostica para demência e comprometimento cognitivo. É breve, simples e pode ser usado em pessoas 
analfabetas. Tornando-o apropriado para o uso em cuidados primários e/ou sujeitos com baixo nível educacional. 
Palavras-chave: meta-análise, rastreio, detecção, comprometimento cogntivo, phototest, demência.
INTRODUCTION
The Phototest (http://www.phototest.es) is a recently developed cognitive test with 
theoretical advantages over other available 
dementia screening tests: it is simple and 
very brief (<3 minutes), can be applied to illit-
erates, and has results that are not influenced 
by the subject’s educational level.1
The test comprises three parts.2 First, a 
naming task with a sheet including the six col-
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or photographs of common objects in prototypic posi-
tion corresponding to different categories (games, vehi-
cles, musical instruments, clothes and eating utensils) is 
administered. These pictured objects vary in frequency, 
from high (car) to low frequency (trumpet); in semantic 
set size, from broad (fruit) to narrow (cutlery); as well 
as in whether they are prototypical (spoon) or atypical 
(shoes) elements in a given semantic field. The sheet is 
then removed. The second task is a verbal fluency test in 
which participants are asked to say as many opposite-
gender names as possible in thirty seconds, and then 
same-gender ones during the same time period. Unlike 
other frequently used verbal fluency tests (e.g. animal 
verbal fluency), this task was shown to be uninfluenced 
by educational level.3 Following the verbal fluency test 
(names of people), which also has a significant distrac-
tor effect between naming and recall tasks; subjects are 
asked to freely recall the six photographs in any order. 
After 20 seconds, the category cues are presented to elic-
it cued recall of only those items that are not retrieved 
by free recall. In summary, the Phototest assesses mul-
tiple cognitive domains including language (naming ob-
jects), executive functions (verbal fluency) as well as epi-
sodic memory (free recall and cued recall), which show 
high sensitivity for detecting cognitive impairment (CI) 
in general, and Alzheimer disease (AD) in particular.4 
Several studies have assessed the diagnostic accuracy 
of the Phototest for detecting cognitive impairment and 
dementia in different settings and sites; however, to date, 
no meta-analysis of these studies has been performed. 
The objective of this systematic review and meta-analysis 
was to evaluate the diagnostic accuracy of the Phototest 
for detecting cognitive impairment and/or dementia.
METHODS
Search criteria for systematic review. A database of pub-
lished and unpublished literature was assembled from 
systematic searches of electronic sources, hand search-
ing, and consultation with experts in the field. The fol-
lowing databases were searched: MEDLINE, PsycINFO, 
EmBASE, SCIELO, and IBECS. In addition, information 
on studies in progress, unpublished research or research 
reported in the grey literature was sought by searching 
a range of relevant databases including Inside Confer-
ences and Dissertation Abstracts. All studies published 
from 1 January 2004 through 31 December 2013 that 
evaluated the diagnostic accuracy of the Phototest for 
detecting cognitive impairment or dementia, were iden-
tified. The search was restricted to English and Spanish 
language literature. With use of a Boolean strategy, cross 
searching of the following four categories was done: 1- 
test (“Fototest” OR “Test de las Fotos” OR “Phototest” 
OR “Photo-Test”), 2- disease (“cognitive impairment” 
OR “dementia” or “Alzheimer´s disease”), 3- estimates 
of diagnostic test accuracy (“sensitivity” OR “specificity” 
OR “accuracy”), and search terms representing screen-
ing tests (“screening” OR “detection”). Furthermore, ad-
ditional articles were identified by manually searching 
the authors’ own literature databases.
Inclusion criteria and selection process. To be included in 
the review, studies had to meet the following criteria: 
[1] population: cognitively healthy older adults or adults 
with cognitive impairment or dementia according to 
validated reference standard diagnostic criteria; [2] out-
come: diagnostic accuracy of the Phototest; and [3] re-
ported data: sensitivity (Sn) and specificity (Sp) values; 
when unavailable, raw data from the articles were used 
to construct 2x2 tables. Authors of individual reports 
were contacted to verify data extracted from the origi-
nal database and to provide supplementary information 
pertaining to the criteria used for diagnosing cognitive 
impairment or dementia.
We developed a data extraction sheet. One review 
author extracted, or calculated from each study, data on 
the sensitivity and specificity of the Phototest while a 
second author checked the extracted data. 
Meta-analysis. For included studies, our primary out-
comes of interest were Sn and Sp at a given cut-off for 
the Phototest. We did not focus on positive and negative 
predictive values because the prevalence of cognitive im-
pairment varied widely across studies. We synthesized 
results for test performance to detect: [1] dementia; and 
[2] cognitive impairment (MCI and/or dementia). We 
ran a random effect meta-analysis (Dersimonian-Laird 
method) for sensitivity and specificity for both groups, 
using the Meta-Disc115 program. Heterogeneity was 
assessed by the Cochran Q test. We also performed a 
meta-analysis of participants including data from au-
thors’ own databases, for which we estimated the area 
under the ROC curve (aROC), Youden index, Sn and Sp 
values, and positive and negative likelihood ratios (+LR, 
–LR), and 95% confidence intervals were calculated for 
all studied variables. Finally, specific LRs were calculated 
for different score intervals. 
The PRISMA-statement was followed for reporting 
items of this systematic review and meta-analyses.6
RESULTS
Literature search. The literature search yielded a total of 
10 potentially relevant articles. We also included 2 addi-
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tional studies conducted in Argentina (an unpublished 
relevant study7 and another ongoing study)8 (Figure 1). 
In total, the articles identified were: two letters to the 
editor,9, 10 one normative study11 and nine diagnostic 
test accuracy studies.1,2,7,8,12-16 Eight references met the 
inclusion criteria for this systematic review. Four stud-
ies were excluded for the following reasons: letter to 
editor (n=2),9,10 duplicated study (n=1),14 and normative 
data study (n=1).11 Finally, two studies were excluded 
from the meta-analysis since they involved a prelimi-
nary version of the Phototest (n=2).1,7 
Diagnostic criteria. All studies from Spain met the Diag-
nostic and Statistical Manual of Mental Disorders–
Fourth Edition, Text Revision (DSM–IV–TR)17 criteria 
for dementia diagnosis, and the recommendations 
from the Spanish Neurological Society for mild cogni-
tive impairment diagnosis (MCI)18. In the Argentine 
study, only subjects who met the National Institute of 
Neurological and Communicative Disorders and Stroke-
Alzheimer’s Disease and Related Disorders Association 
(NINDS-ADRDA)19 criteria for probable Alzheimer-type 
dementia, the DSM-IV-TR17 criteria for dementia, and 
the conventional Petersen criteria20 for single domain 
amnestic MCI were included.
Characteristics of included studies. The systematic review 
included 8 articles (n=1939 participants, ranging from 
60 to 589 subjects). The details of the included studies 
are summarized in Table 1 and explained below:
Preliminary Study1 – Case-control study providing 
“proof of concept” of the Phototest. This early version 
of the test used a sheet with 6 photographs of objects, 
different to those in the current version, therefore the 
study was excluded from the current analysis. 
Cross-sectional Study2 – Cross-sectional prospective 
study of subjects attending a Cognitive-Behavioral Neu-
rological Unit. The reference standard (clinical diagno-
sis) was independent and blind to the Phototest results.
Argentine-1 Study7 – Cross-sectional study performed 
in a subgroup of patients with established diagnosis, at-
tending elderly day care centers or nursing homes. This 
study was excluded because it used the earlier version of 
the Phototest. 
Ciudad Real Study12 – Cross-sectional study performed 
in a simple random sample of individuals corresponding 
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Figure 1. Study selection flow chart based on PRISMA-statement.
Ciudad Real. Only presence or absence of dementia was 
considered. Diagnosis and the Phototest application 
were carried out by independent investigators. Individ-
ual results for this study were not available. 
FOTOTRANS Study15 – Cross-sectional multi-center 
naturalistic study conducted in individuals with previ-
ous diagnosis during 19 visits to General Neurology De-
partments. 
Granada Study13 – Prospective study of consecutive pa-
tients suspected of dementia attending four health cen-
ters in Granada. The reference standard (clinical diag-
nosis) was established by blinded trained neurologists 
from Cognitive-Behavioral Neurology Unit. 
AD8 Study16 – Cross-sectional, prospective study con-
ducted at a Cognitive-Behavioral Neurology Unit, which 
served as validation of the Spanish version of the AD8 
questionnaire (20). In this study, the Phototest was 
used as a short cognitive reference test to compare and 
assess construct validity of the AD8 questionnaire.21 
Argentine-2 Study8 – Cross-sectional study of elderly 
clinical patients attending two memory clinics in Argen-
tina, selected by convenience sampling of consecutive 
patients suspected of cognitive impairment or dementia.
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Cut-off points. The optimal cut-off scores for identifying 
dementia in the studies included varied between 24/25 
and 26/27 (positive/ negative). For discriminating be-
tween control and cognitive impairment subjects, the 
optimal cut-off score of the Phototest was 28/29 in the 
Spanish study and 30/31 in the Argentine sample.
Apart from published information, all individual 
data were available for 5 out of the 6 included stud-
Table 1. Description of individual studies of diagnostic accuracy of the Phototest included in the meta-analysis 
Study, year Site Setting n
Dementia Cognitive Impairment Meta-analyses











60 0.50 0.93 0.80 – – – No No
Carnero-Pardo C, 
et al., 2007
Granada Specialized care 378 0.25 0.88 0.90 0.49 0.90 0.90 Yes Yes
Barreto MD, 
et al., 2007
Buenos Aires Residential care 73 0.16 0.85 0.96 0.37 0.83 0.90 No No
Baos Sánchez L, 
et al., 2008





138 0.34 0.81 0.89 0.60 0.71 0.84 Yes Yes
Carnero-Pardo C, 
et al., 2012
Multicenter Neurological care 589 0.20 0.88 0.87 0.39 0.69 0.93 Yes Yes
Carnero-Pardo C, 
et al., 2013
Granada Specialized care 313 0.45 0.84 0.90 0.70 0.83 0.96 Yes Yes
Russo MJ, 
et al., 2012
Buenos Aires Specialized care 127 0.44 0.79 0.73 0.80 0.90 0.90 Yes Yes
Sn: sensitivity; Sp: specificity.
Figure 2. Meta-analysis of sensitivity for dementia.
Figure 3. Meta-analysis of specificity for dementia.
ies2,8,13,15,16 and a meta-analysis of individual participant 
data was performed. 
Meta-analysis 
Dementia – The overall prevalence of dementia for 
studies in different settings was 30.5 %. Sn and Sp di-
agnostic parameters for dementia are shown in Table 1. 
For all dementia subjects, the pooled estimate of Sn was 
0.85 (95% CI, 0.82-0.88) with no evidence of significant 
heterogeneity between studies (Q=4.71, p=0.32) (Fig-
ure 2); and the pooled estimate of Sp was 0.87 (95% CI, 
0.85-0.89) with evidence of significant heterogeneity 
(Q=17.3, p<0.01) (Figure 3). 
In the meta-analysis of individual participant data, 
1565 subjects were included (1104 without dementia 
and 461 with dementia); the aROC was 0.94 (95% CI, 
0.93-0.95) and the value that maximizes the sum of 
Sn and Sp was 26/27, with Sn and Sp of 0.89 (95% CI, 
0.85-0.91) and 0.84 (95% CI, 0.82-0.86), respectively. 
Diagnostic accuracy parameters (Sn, Sp, +LR, -LR and 
Youden index) for different cut-offs of pooled individual 
data are shown in Table 2. 
Cognitive impairment. Sn and Sp diagnostic parameters 
for cognitive impairment are shown in Table 1. In all 
studies, subjects with dementia are included in cogni-
tive impairment group. In the random-effects meta-
analysis, Sn was 0.80 (95% CI, 0.77-0.92) with evidence 
of significant heterogeneity between studies (Q=34.8, 
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p<0.001) (Figure 4), and Sp was 0.88 (95% CI, 0.86-
0.90) also showing significant heterogeneity (Q=13.7, 
p<0.01) (Figure 5). 
In the meta-analysis of individual data, a total of 
1565 subjects were included (766 without cognitive 
impairment and 799 with cognitive impairment); the 
aROC was 0.91 (95% CI, 0.93-0.92) and the cut-off point 
maximizing the Sn + Sp value was 28/29, with estimat-
ed Sn and Sp of 0.79 (95% CI, 0.76-0.81) and 0.88 (95% 
CI, 0.86-0.90), respectively. Diagnostic accuracy param-
eters (Sn, Sp, +LR, -LR and Youden index) for different 
cut-offs of pooled individual data are shown in Table 3. 
The meta-analysis of individual data also allowed es-
timation of specific LRs for different cut-off points or 
intervals for dementia (Table 4) and cognitive impair-
ment (Table 5). 
Table 2. Results of the meta-analysis of individual participant data based on parameters estimated for dementia.
Cut-off Sn (95 %CI ) Sp (95 %CI ) +LR (95 %CI ) –LR (95 %CI ) Youden index
23/24 0.71(0.67-0.75) 0.94 (0.92-0.95) 11.72 (9.2-14.9) 0.31 (0.3-0.4) 0.65
24/25 0.78 (0.74-0.82) 0.92 (0.90-0.94) 10.00 (8.1-12.3) 0.24 (0.2-0.3) 0.70
25/26 0.82 (0.79-0.86) 0.88 (0.82-0.90) 7.11 (6.0-8.4) 0.20 (0.2-0.2) 0.70
26/27 0.89 (0.86-0.92) 0.84 (0.80-0.85) 5.47 (4.8-6.3) 0.13 (0.1-0.2) 0.73
27/28 0.92 (0.90-0.95) 0.78 (0.76-0.81) 4.29 (3.8-4.8) 0.10 (0.07-0.1) 0.70
28/29 0.96 (0.93-0.97) 0.75 (0.72-0.77) 3.81 (3.4-4.2) 0.06 (0.04-0.1) 0.71
29/30 0.97 (0.96-0.99) 0.61 (0.58-0.64) 3.01 (2.8-3.3) 0.05 (0.03-0.08) 0.58
+LR, –LR: positive and negative likelihood ratios; Sn: sensitivity; Sp: specificity.
Figure 4. Meta-analysis of sensitivity for cognitive impairment. Figure 5. Meta-analysis of specificity for cognitive impairment.
Table 3. Results of the meta-analysis of individual participant data based on parameters estimated for cognitive impairment.
Cut-off Sn (95 %CI ) Sp (95 %CI ) +LR (95 %CI ) –LR (95 %CI ) Youden index
26/27 0.68 (0.65-0.72) 0.95 (0.93-0.96) 12.8 (9.5-17.3) 0.33 (3-0.4) 0.63
27/28 0.75 (0.72-0.79) 0.91 (0.89-0.93) 8.7 (6.9-11.0) 0.28 (0.2-0.3) 0.66
28/29 0.79 (0.76-0.81) 0.88 (0.86-0.90) 6.7 (5.5-8.1) 0.24 (0.2-0.3) 0.67
29/30 0.83 (0.81-0.86) 0.82 (0.80-0.85) 4.73 (4.0-5.5) 0.20 (0.2-0.2) 0.65
30/31 0.88 (0.86-0.90) 0.77 (0.74-0.80) 3.83 (3.4-4.4) 0.16 (0.1-0.2) 0.65
31/32 0.91 (0.88-0.93) 0.68 (0.65-0.72) 2.86 (2.6-3.2) 0.14 (0.1-0.2) 0.59
32/33 0.93 (0.91-0.95) 0.58 (0.55-0.62) 2.25 (2.1-2.4) 0.12 (0.09-0.2) 0.51
+LR, –LR: positive and negative likelihood ratios; Sn: sensitivity; Sp: specificity.
Table 4. Post-test probabilities (predictive values) of the Phototest for differ-
ent cut-off intervals for dementia.
Phototest Dementia Cognitive impairment LR
0-20 220 16 32.93
21-23 108 51 5.07
24-26 81 112 1.73
27-29 37 176 0.50
≥30 15 769 0.05
Total 461 1104
LR: likelihood ratios. 
Table 5. Post-test probabilities (predictive values) of the Phototest for differ-
ent cut-off intervals for cognitive impairment.
Phototest Dementia Cognitive impairment LR
0-24 233 15 27.50
25-27 168 51 3.16
28-30 105 100 1.00
31-33 57 217 0.25
≥34 39 373 0.10
Total 799 766
LR: likelihood ratios. 
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DISCUSSION
In this systematic review, we found a total of 8 studies 
concerning Phototest diagnostic accuracy, 6 of which 
were included in the meta-analysis,2,8,12,13,15,16 whereas 
2 studies were excluded because they employed a pre-
liminary pilot version of the test.1,7 Results showed ac-
ceptable diagnostic accuracy parameters for dementia, 
with better Sp (0.87, 95% CI 0.82-0.88) than Sn (0.85, 
95% CI 0.82-0.88). Estimates for cognitive impairment 
also showed higher Sp (0.88, 95% CI 0.85-0.91) than Sn 
(0.80, 95% CI 0.77-0.92). Similar results were found in 
the meta-analysis of individual participant data, with 
optimal cut-off points of 26/27 for dementia (Sn=0.89, 
95% CI 0.85-0.91; Sp=0.84, 95% CI 0.82-0.86) and 
28/29 for cognitive impairment (Sn=0.79, 95% CI 0.76-
0.81; Sp=0.88, 95% CI 0.86-0.90). In the latter analysis, 
we calculated clinically relevant score intervals and their 
corresponding LRs. This allowed estimation of pooled 
post-test probability for known sample prevalence.22 
Studies were heterogeneous regarding number of 
subjects included, variable settings, cut-off points used 
and quality of data. They were however, highly homo-
geneous with respect to diagnostic criteria since, except 
for the Argentine-2 study, authors used the same diag-
nostic criteria, namely: DSM-IV-TR17 for dementia and 
MCI criteria from the Spanish Neurological Society18 for 
cognitive impairment. The Argentine-2 study only in-
cluded patients with probable Alzheimer´s disease and 
single domain amnestic MCI. 
It is known that the Mini-Mental State Examina-
tion (MMSE)23 is the most commonly used cognitive 
screening test. However, a meta-analysis of the accuracy 
of the MMSE24 revealed its very limited value in detect-
ing dementia (Sn=0.77, 95% CI 0.70-0.83; Sp=0.90, 
95% CI 0.82-0.95), and particularly MCI (Sn=0.67, 95% 
CI 0.50-0.82; Sp=0.78, 95% CI 0.62-0.90). These re-
sults are in line with a side-by-side comparison of the 
two instruments, in which the Phototest proved to be 
more efficient due to superior effectiveness and lower 
cost than the MMSE.13 In addition to lower effective-
ness, the MMSE has numerous other limitations (lack 
of standardization, application time, influence of socio-
educational variables and copyright). These drawbacks 
have led one of the authors to suggest this could be the 
right time to reject this test.25
The Eurotest26 is another instrument which can be 
used in illiterate persons that is independent of socio-
educational factors and has shown similar diagnostic 
accuracy to the Phototest in a recent meta-analyses27 
(aROC=0.94 in both studies) exhibiting higher Sn 
(0.91[0.88-0.94]) and lower Sp (0.84[0.82-0.86]). An-
other study with a side-by-side comparison of the Eu-
rotest and Phototest showed the same effectiveness.14 If 
we consider that the Eurotest requires double the time 
to apply (6 to 8 min) than the Phototest (<3 min), de-
spite being equally effective, the latter proves to be more 
efficient and useful in clinical practice.
The Clock Drawing Test28 is another brief and wide-
ly-used cognitive test. However, in a recent systematic 
review,29 a quantitative meta-analysis was unfeasible 
due to the large variety of correction systems applied 
in publications. Two recent studies have shown mod-
est utility both in specialized (aROC=0.88 for dementia, 
aROC=0.82 for cognitive impairment)30 and in primary 
care settings (aROC=0.84 for CI).31 These poor results 
may be linked to low educational level of the study pop-
ulations, since it is known that education greatly influ-
ences test results.29,32 
The main limitations of this meta-analysis are the 
study heterogeneity and the small sample size of some 
of the studies included. Its strengths include the homo-
geneity of the diagnostic criteria used, the varied study 
locations which comprised multiple clinical settings, 
and above all, the individual participant data analysis 
that included data from all studies, bar one. This meta-
analysis allowed robust estimation of diagnostic accu-
racy parameters for either point estimate or interval 
results.
In conclusion, this meta-analysis showed that the 
Phototest offers adequate diagnostic accuracy for cogni-
tive impairment, and particularly for dementia, that is 
similar or superior to other instruments widely used in 
our milieu. Additionally, it is simple, brief, uninfluenced 
by educational variables and can even be used in indi-
viduals who are illiterate. These advantages make it at-
tractive for use in populations with low educational lev-
el and/or in time-limited settings such as primary care.
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